Iguratimod reduces panel reactive antibody in high mismatched renal transplant recipients: One single-center experience.
Dengyuan FengZhengkai HuangHao ChenJun TaoXiang GaoJiawen LiuLi SunZijie WangZhijian HanXiaobing JuRuoyun TanMin GuPublished in: Clinical transplantation (2022)
PRA levels in high-mismatched renal transplant recipients were significantly reduced after the administration of IGU. The high safety of IGU was also determined.
Keyphrases